Consistent with the previous report that SETDB1 is an oncogene in breast cancer and plays an important role in treating endocrine therapy resistance [33, 50–52], our study reveals that SETDB1 is critical for BCSC properties, chemotherapy resistance, and metastasis. This evidence concerns the gene SETDB1 and breast carcinoma.